My take on the OSA trial is that they have a product that is effective, it’s the residual thc that needs addressing. If they can organise this then the rather bright lights come on . IMO
- Forums
- ASX - By Stock
- IHL
- Ann: RESUBMISSION - Quarterly Update and Appendix 4C
Ann: RESUBMISSION - Quarterly Update and Appendix 4C, page-33
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)